Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04451135 · ClinicalTrials.gov registry record · NA
CET- REM (Correlating ECT Response to EEG Markers)
A NA study of Treatment-Resistant Depression and ECT, sponsored by Washington University School of Medicine.
- Active
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04451135: Active NA study of Treatment-Resistant Depression and ECT, sponsored by Washington University School of Medicine.
NCT04451135 is a NA study of Treatment-Resistant Depression and ECT that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 31 participants, below the 373-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04451135, a NA study of Treatment-Resistant Depression and ECT, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Single-center study to determine the relationship between changes in depression symptoms and electroencephalographic (EEG) patterns induced by electroconvulsive therapy (ECT)
Primary Outcome
16 item Self-report questionnaire that best describes the participant's depressive symptoms over the last seven days. Scale: 0=never or do not, 3=nearly all the time, or the highest level of time listed on the question.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Electroencephalographic (EEG)
- DIAGNOSTIC_TEST Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16)
- DIAGNOSTIC_TEST Ictal Electroencephalographic (EEG) Measurements
- DIAGNOSTIC_TEST Post-Ictal Electroencephalographic (EEG) Suppression Measurements
Study Locations (1)
Missouri
- Washington University School of Medicine/Barnes-Jewish Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-10-09 |
| Est. Completion | 2027-06 |
| Phase | NA |
What the registry record for NCT04451135 still lists
NCT04451135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 373-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Treatment-Resistant Depression appearing as the primary indexed condition, and to 4 interventions - of which Electroencephalographic (EEG) is the first listed.
NCT04451135 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04451135 about?
NCT04451135 is a clinical study titled "CET- REM (Correlating ECT Response to EEG Markers)". Single-center study to determine the relationship between changes in depression symptoms and electroencephalographic (EEG) patterns induced by electroconvulsive therapy (ECT)
What is the current status of trial NCT04451135?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2020-10-09. Estimated completion is 2027-06.
What conditions does trial NCT04451135 study?
This clinical trial studies the following conditions: Treatment-Resistant Depression, ECT.
What interventions are being tested in trial NCT04451135?
The interventions under investigation include: Electroencephalographic (EEG) (DIAGNOSTIC_TEST), Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16) (DIAGNOSTIC_TEST), Ictal Electroencephalographic (EEG) Measurements (DIAGNOSTIC_TEST), Post-Ictal Electroencephalographic (EEG) Suppression Measurements (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04451135?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04451135 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Treatment-Resistant Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04451135's enrollment target sits among peer trials
31 37th of 54 higher than 18 of 54 other Treatment-Resistant Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Treatment-Resistant Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
RECRUITING · NA
-
Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing
RECRUITING · NA
-
DBS for TRD With the Medtronic Percept PC
RECRUITING · NA
-
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
RECRUITING · NA
-
PCS in Severe Treatment Resistant Depression
RECRUITING · NA
-
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI